The anti-cancer activity of HER2-specific CAR T cells with long spacers differed, with HER2-LS-28/ζ CAR T cells achieving slightly delayed tumor eradication in all mice and HER2-LS-4-1BB/ζ CAR T cells failing to induce any significant tumor regression. This evidence concerns the gene ERBB2 and cancer.